Shenzhen Bioeasy Biotechnology Co Ltd

Chart & Performance

D1W1MN

P/E

181.86

P/S

9.49

EPS

0.03

Div Yield, %

0.29%

Shrs. gr., 5y

3.05%

Rev. gr., 5y

-15.12%

Revenues

263m

+17.38%

Net income

14m

-19.71%

CFO

67m

+95.20%

Dividend

May 28, 20250.0174399 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Founded in 2007 and headquartered in Shenzhen, China, Shenzhen Bioeasy Biotechnology Co., Ltd. specializes in the development and commercialization of rapid testing instruments and reagents throughout the Chinese market. The company's comprehensive diagnostic equipment addresses a wide array of applications, spanning food and agricultural analysis, dairy, meat, and aquatic product testing, honey quality control, drug detection, public safety measures, and clinical diagnostics.

URL

http://www.bioeasy.com/

IPO date

Feb 09, 2021

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2023‑00	2022‑12	2022‑00	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT